Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

The $1,000 Infection Tax

Photo creation by RRY Publications, LLC, Wikimedia Commons, Ottoman Jackson, and DataBase Center for Life Science

In this new era of cost containment in medicine, adding over $1,000 to the cost of a procedure sounds fiscally irresponsible. A group of new studies about post op infection rates provide new insights into this critical issue as contributing commentator, Jay Mabrey, M.D., MBA, CPE explains.


New MIS Spine Study Group Launch; New Study Targets Cellular RA Triggers; Active Implants Names Ted Davis President, CEO

Kern Singh, M.D. / Courtesy of Midwest Orthopaedics at Rush, Wikimedia Commons, and Brandonng06

Kern Singh, M.D. is advancing the science of spine with the establishment of the MISSG. New research suggests that we need to look deeper into RA to treat it. Ted Davis, 25-year veteran of life sciences, takes helm at Active Implants.

2nd Settlement in Glucosamine Chondroitin Lawsuit

Photo creation by RRY Publications, LLC

A massive class action lawsuit against suppliers of Glucosamine Chondroitin and their retailers is moving to a second settlement. This new deal gives thousands of patients a higher award, there will likely be no funds leftover for the Orthopedic Research and Education Foundation. Which is a big bummer. Here are the details.


New Evidence: Mild Concussions Related to ALS

Source: Wikimedia Commons and shgmom56 on Flickr

A new concussion model developed by Gretchen Thomsen, Ph.D., of the Regenerative Medicine Institute at Cedars-Sinai Medical Center in Los Angeles and colleagues triggered earlier onset of familial Amyotrophic Lateral Sclerosis symptoms. The researchers hope that the model can be used to develop novel therapies.